Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2012
05/18/2012WO2012064721A2 Medulloblastoma genes as targets for diagnosis and therapeutics
05/18/2012WO2012064704A1 Multi-function microfluidic test kit
05/18/2012WO2012064674A1 Materials and methods for immunoassay of pterins
05/18/2012WO2012064671A1 Compositions and methods for increasing drug efficacy in cancer
05/18/2012WO2012064639A1 Method and apparatus for visualizing contraction stress from curable materials
05/18/2012WO2012064501A1 Hydroxycholesterol immunoassay
05/18/2012WO2012064381A1 Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates
05/18/2012WO2012064367A2 Treatment of ruminant exhalations
05/18/2012WO2012064322A1 Gas sensor testing device
05/18/2012WO2012064252A1 Multifunctional breath analyzer
05/18/2012WO2012063875A1 Markers for detecting human follicular helper t cells and method for detecting human follicular helper t cells
05/18/2012WO2012063866A1 Method for quantification of remnant-like lipoprotein cholesterol and kit for same
05/18/2012WO2012063844A1 Analysis method and device
05/18/2012WO2012062945A1 Functionalized boscalid derivatives
05/18/2012WO2012062910A1 Isolation and functional identification of cells
05/18/2012WO2012062861A1 New adjuvant
05/18/2012WO2012062831A1 Method for the diagnosis and/or follow up of the evolution of a tumor
05/18/2012WO2012062651A1 Device for filtering blood
05/18/2012WO2012062354A1 Method for the selection of compounds useful for the treatment of psychiatric and neurodegenerative diseases
05/18/2012WO2012062325A1 Enrichment and identification of fetal cells in maternal blood and ligands for such use
05/18/2012WO2012062319A1 Radiolabelled phenylimidazole-based ligands
05/18/2012WO2012062318A1 Quantification of single target molecules in histological samples
05/18/2012WO2012061957A1 Apparatus for body fluid tests with testing and storing functions
05/18/2012WO2012061927A1 Selective glycosidase inhibitors and uses thereof
05/18/2012WO2012061904A1 Histone protein ubiquitination as a cancer biomarker
05/18/2012WO2012061898A1 Method of assessing oocytes
05/18/2012WO2012061882A1 Treatment and prevention of malaria
05/18/2012WO2012037361A3 Methods of use and kit for measurement of lipopolysaccharide with a time resolved fluorescence based assay
05/18/2012WO2012035508A3 Method for separating target molecules or particles from fibrinogen-containing samples including blood components
05/18/2012WO2012034013A3 Detection of rna-interacting regions in dna
05/18/2012WO2012034007A3 Size selection of dna for chromatin analysis
05/18/2012WO2012030256A3 Sensitizer and erythrocytic diagnostic agent for diagnosing malignant neoplasms, methods for producing same
05/18/2012WO2012028167A3 Acridinium ester chemiluminescence upon reductive triggering
05/18/2012WO2012027717A3 Flourescence labeling reagents and uses thereof
05/18/2012WO2012027546A3 Poised th17 cells, methods of isolation, and methods of use
05/18/2012WO2012027542A3 Simultaneous orthogonal light sheet microscopy and computed optical tomography
05/18/2012WO2012025873A3 STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS
05/18/2012WO2012025637A9 An agglutination assay method and device
05/18/2012WO2012024623A3 Sox9 as a marker for aggressive cancer
05/18/2012WO2012023112A3 Bard1 isoforms in lung and colorectal cancer and use thereof
05/18/2012WO2012021741A3 Lateral flow assays for non-diagnostic analytes
05/18/2012WO2012018855A3 Systems and methods for immunosorbent assays for single and multiple analytes
05/18/2012WO2012016136A3 Microscale and nanoscale structures for manipulating particles
05/18/2012WO2012015219A3 Real-time monitoring of depletion of high-abundance blood proteins or recovery of low-abundance blood proteins by uv spectrometry
05/18/2012WO2012012428A3 Systems and methods for identifying a discontinuity in the boundary of an object in an image
05/18/2012WO2012012225A9 Predicting cancer outcome
05/18/2012WO2012009554A3 Methods and systems for in vivo clinical data measurement of analytes
05/18/2012WO2012009239A3 Sensors and separation based on molecular recognition via electropolymerization and colloidal layer templates
05/18/2012WO2012008807A3 Use of tgase2 and vhl as a diagnostic marker for renal cell carcinoma
05/18/2012WO2012006632A3 Lung cancer biomarkers and uses thereof
05/18/2012WO2012006406A3 Analyte mass spectrometry quantitation using a universal reporter
05/18/2012WO2011159847A3 Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof
05/18/2012WO2011150994A3 Serum and tissue biomarkers of human hcc
05/18/2012WO2011143574A3 Plasma biomarkers for diagnosis of alzheimer's disease
05/18/2012WO2011132077A3 Diagnostic assay
05/18/2012WO2011131178A3 Method for detecting a salmonella infection
05/18/2012WO2011122859A3 Composition for predicting chance of brain tumor recurrence and survival prognosis, and kit containing same
05/18/2012WO2011119986A3 Methods for culturing and analyzing cells
05/18/2012WO2011110838A3 Therapeutic treatments and screening methods using p63
05/18/2012WO2011100435A9 Automated drilling fluid analyzer
05/18/2012WO2011056606A8 Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
05/18/2012WO2010084296A3 Flue-gas analysis safety apparatus
05/18/2012CA2817851A1 Albumin-bound protein/peptide complex as a biomarker for disease
05/18/2012CA2817847A1 Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease
05/18/2012CA2817568A1 Cancer therapies and diagnostics
05/18/2012CA2817514A1 Salted food product
05/18/2012CA2817421A1 New adjuvant
05/18/2012CA2817418A1 Highly immunogenic hiv p24 sequences
05/18/2012CA2817390A1 Enrichment and identification of fetal cells in maternal blood and ligands for such use
05/18/2012CA2817385A1 Radiolabelled phenylimidazole-based ligands
05/18/2012CA2817311A1 Counting particles using an electrical differential counter
05/18/2012CA2817202A1 Hydroxycholesterol immunoassay
05/18/2012CA2816603A1 Materials and methods related to microrna-21, mismatch repair, and colorectal cancer
05/18/2012CA2816472A1 Quantification of single target molecules in histological samples
05/18/2012CA2815840A1 Methods and compositions for neural disease immunotherapy
05/18/2012CA2806920A1 Method and apparatus for visualizing contraction stress from curable materials
05/17/2012US20120124687 Lolium perenne subsp. stoloniferum; perennial ryegrass with determinate-stolons
05/17/2012US20120124376 Information Processing System Using Nucleotide Sequence-Related Information
05/17/2012US20120123738 Closing device, housing part of a lubricant container, diagnostic system and diagnostic method for monitoring the operating state of a lubricant in the housing part
05/17/2012US20120123695 Methods for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies
05/17/2012US20120123689 Methods and systems for discriminating bands in scalograms
05/17/2012US20120123685 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
05/17/2012US20120123026 Functionalized compositions for improved immobilization
05/17/2012US20120122991 Method for treating cancer by increasing amp-activated kinase activity
05/17/2012US20120122981 Biomarkers Related to Insulin Resistance and Methods using the Same
05/17/2012US20120122958 Transcriptional repression leading to parkinson's disease
05/17/2012US20120122957 Regulation of aging by modulation of mitochondrial function
05/17/2012US20120122840 Compounds and therapeutic uses thereof
05/17/2012US20120122819 Guanine riboswitch binding compounds and their use as antibiotics
05/17/2012US20120122777 Diagnostic agent for ischemic heart disease risk group
05/17/2012US20120122771 STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN
05/17/2012US20120122762 186 Human Secreted Proteins
05/17/2012US20120122761 Methods for detecting a polymorphism in the nfkb1 gene promoter
05/17/2012US20120122735 Composition, device and associated method
05/17/2012US20120122734 Composition, device and associated method
05/17/2012US20120122733 Composition, device and associated method
05/17/2012US20120122732 Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
05/17/2012US20120122726 Markers for endometrial cancer
05/17/2012US20120122724 Agents and Methods Related to Reducing Resistance to Apoptosis-Inducing Death Receptor Agonists
05/17/2012US20120122723 Methods of detecting autoantibodies for diagnosing and characterizing disorders
1 ... 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 ... 3937